Literature DB >> 18038978

Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet.

Natalizia Miceli1, Maria R Mondello, Maria T Monforte, Vasileios Sdrafkakis, Paola Dugo, Maria L Crupi, Maria F Taviano, Rita De Pasquale, Ada Trovato.   

Abstract

Citrus bergamia Risso et Poiteau fruits have been traditionally utilized, in Calabria (Italy), as a popular remedy for their hypolipidemic properties. C. bergamia juice total phenol content (2474.35+/-38 microg/mL) was evaluated by the Folin-Ciocalteu method; moreover, HPLC analysis led to the identification of naringin (520 ppm), neoeriocitrin (370 ppm), and neohesperidin (310 ppm). The present study was designed to investigate the hypolipidemic effects of C. bergamia juice and its protective effect on liver of hyperlipidemic rats. Chronic administration of C. bergamia (1 mL/rat/day) provoked a significant reduction in serum cholesterol, triglycerides, and low-density lipoprotein (LDL) levels and an increase in high-density lipoprotein (HDL) levels; moreover, histopathological observations showed, in rats submitted to C. bergamia treatment, a protection of hepatic parenchyma. In addition, fecal neutral sterols and fecal bile acid excretion was found to be increased after C. bergamia treatment. These results suggest that the hypocholesterolemic effect of C. bergamia may be mediated by the increase in fecal neutral sterols and total bile acids excretion. In addition to the hypolipidemic effect, the juice shows radical scavenging activity in the diphenylpicrylhydrazyl (DPPH) test; probably the two effects are related. These observations suggest that the positive intake of C. bergamia may reduce the risk of some cardiovascular diseases through its radical scavenging function and hypocholesterolemic action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038978     DOI: 10.1021/jf071772i

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  16 in total

1.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-08-04       Impact factor: 3.318

2.  Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers.

Authors:  Mirielle C Nauman; Jeremy J Johnson
Journal:  Integr Food Nutr Metab       Date:  2019-02-28

Review 3.  Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.

Authors:  Federica Scarano; Micaela Gliozzi; Maria Caterina Zito; Lorenza Guarnieri; Cristina Carresi; Roberta Macrì; Saverio Nucera; Miriam Scicchitano; Francesca Bosco; Stefano Ruga; Anna Rita Coppoletta; Rocco Mollace; Jessica Maiuolo; Irene Bava; Antonio Cardamone; Monica Ragusa; Ernesto Palma; Vincenzo Musolino; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

4.  Quorum sensing inhibitory effect of bergamot oil and aspidosperma extract against Chromobacterium violaceum and Pseudomonas aeruginosa.

Authors:  Sarah Omar Ahmed; Hamdallah Hafez Zedan; Yasser Musa Ibrahim
Journal:  Arch Microbiol       Date:  2021-06-27       Impact factor: 2.552

5.  Finger Citron Extract Ameliorates Glycolipid Metabolism and Inflammation by Regulating GLP-1 Secretion via TGR5 Receptors in Obese Rats.

Authors:  Yujiao Yang; Aofei Tian; Zhen Wu; Yao Wei; Xuguang Hu; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-27       Impact factor: 2.629

6.  Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes.

Authors:  Roberto Risitano; Monica Currò; Santa Cirmi; Nadia Ferlazzo; Pietro Campiglia; Daniela Caccamo; Riccardo Ientile; Michele Navarra
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

7.  Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.

Authors:  Yong Cai; Guoqiang Xing; Tian Shen; Shuxian Zhang; Jianyu Rao; Rong Shi
Journal:  Lipids Health Dis       Date:  2017-12-22       Impact factor: 3.876

8.  Antioxidative and Cholesterol-Lowering Effects of Lemon Essential Oil in Hypercholesterolemia-Induced Rabbits.

Authors:  Hyunjoo Lee; Minji Woo; Mijeong Kim; Jeong Sook Noh; Yeong Ok Song
Journal:  Prev Nutr Food Sci       Date:  2018-03-31

9.  In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori.

Authors:  Angela Filocamo; Carlo Bisignano; Nadia Ferlazzo; Santa Cirmi; Giuseppina Mandalari; Michele Navarra
Journal:  BMC Complement Altern Med       Date:  2015-07-30       Impact factor: 3.659

10.  Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Authors:  Peter P Toth; Angelo M Patti; Dragana Nikolic; Rosaria V Giglio; Giuseppa Castellino; Teresa Biancucci; Fabiana Geraci; Sabrina David; Giuseppe Montalto; Ali Rizvi; Manfredi Rizzo
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.